Cancers and other diseases can be treated with two or three types of agents: an agent which induces lymphodepletion or lymphopenia an inhibitory antibody to a surface marker on Treg cells and optionally a specific antigen. This combination may lead to enhanced immune responses despite lymphodepletion or lymphopenia.